Skip to main content

Day: July 14, 2020

Saint Jean Carbon no longer acquiring Process Research Ortech

OAKVILLE, Ontario, July 14, 2020 (GLOBE NEWSWIRE) — Saint Jean Carbon Inc. (“Saint Jean” or the “Company”) (TSX-V: SJL) (OTCQB: TORVF), a carbon science company engaged in the design and build of green energy storage, green energy creation and green re-creation through the use of carbon materials.  With reference to the News Release dated July 9th, 2019, the Company wishes to announce that it is not proceeding with the previously announced acquisition of Process Research Ortech (“Ortech”).  As of the date of this announcement, the Company has not received documentation that is both required and customary for a fundamental acquisition of this nature.  In addition, the Company believes that the market would not support the proposed transaction during these trying times.  The Company and Ortech are committed to continue working together...

Continue reading

Merus et Caris Life Sciences annoncent une collaboration visant à détecter les fusions du gène NRG1 chez des patients atteints d’un cancer

Caris fournira des tests moléculaires d’ADN et d’ARN afin de soutenir l’identification et le recrutement des patients pour l’essai eNRGy de phase 1/2 sur Zenocutuzumab de MerusUTRECHT, Pays-Bas, CAMBRIDGE, Massachusetts, et IRVING, Texas, 14 juill. 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq : MRUS), une société d’oncologie de stade clinique qui développe des anticorps multispécifiques pleine longueur (Biclonics® et Triclonics™), et Caris Life Sciences, un innovateur de premier plan en science moléculaire axé sur l’accomplissement de la promesse de la médecine de précision, ont annoncé aujourd’hui une collaboration visant à détecter les fusions de la néuréguine 1 (NRG1) chez les patients atteints d’un cancer. En vertu de l’accord, Caris a accepté d’effectuer le séquençage...

Continue reading

Merus und Caris Life Sciences geben Zusammenarbeit beim Nachweis von NRG1-Fusionen bei Krebspatienten bekannt

Caris stellt molekulare DNA- und RNA-Tests zur Verfügung, um die Identifizierung und Teilnahme von Patienten für die Zenocutuzumab-eNRGy-Studie der Phase I/II von Merus zu unterstützenUTRECHT, Niederlande, und CAMBRIDGE, Mass. und IRVING, Texas, July 14, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), ein Unternehmen im Bereich der klinischen Onkologie, das innovative humane multispezifische Antikörper entwickelt (Biclonics® und Triclonics™), und Caris Life Sciences®, ein führender Innovator in der Molekularwissenschaft, der sich darauf konzentriert, das Versprechen der Präzisionsmedizin einzulösen, gaben heute ihre Zusammenarbeit beim Nachweis von Neuregulin 1 (NRG1)-Fusionen bei Krebspatienten bekannt. Im Rahmen der Vereinbarung hat sich Caris bereit erklärt, bei bestimmten Krebspatienten (überwiegend an Pankreaskrebs erkrankte),...

Continue reading

Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock

SEATTLE, July 14, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced today the commencement of a proposed underwritten public offering of 8,000,000 shares of its common stock (6,000,000 of which are being offered for sale by Adaptive and 2,000,000 of which are being offered for sale by a selling shareholder). In addition, Adaptive expects to grant the underwriters a 30-day option to purchase up to 1,200,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering...

Continue reading

Calian Grows Cyber Team with Acquisition of Boutique Emissions Security Consultancy

OTTAWA, July 14, 2020 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY) has acquired EMSEC Solutions Inc. (EMSEC), a boutique firm specializing in radio frequency (RF) emission security and technical surveillance countermeasures.Emissions security relates to the control and prevention of unintentional electrical and electromagnetic emissions that can disclose sensitive or classified information. EMSEC provides technical and professional services including TEMPEST products and other mitigation techniques such as facility zoning (physical distancing, building modifications, separation of IT systems, and other measures). This specialized field is growing as organizations increasingly see a need to protect intellectual property.EMSEC’s customized services include vulnerability assessments, monitoring, training, risk mitigation and countermeasure...

Continue reading

Patagonia Gold First Quarter 2020 Financial Results

VANCOUVER, British Columbia, July 14, 2020 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) is pleased to announce its unaudited results for the fiscal period ended March 31, 2020 (“Q1 2020”).  The financial statements together with the management’s discussion and analysis (“MD&A”) are available on the Company’s website and on SEDAR at www.sedar.com.HighlightsRevenue of US $5.22 million and gross profit of US $2.77 million in Q1 2020.Total production of 1,937 gold ounces and 41,377 silver ounces in Q1 2020.Requested quotations for potential construction of underground mine at Cap-Oeste gold / silver project and successfully completed bulk metallurgical tests at the Martha process plant located 100 km south east of Cap-Oeste.Received regulatory approval for Normal Course Issuer Bid to re-purchase...

Continue reading

CB2 Insights Announces Quarterly Revenue of $2.93 million for Q1 2020. EBITDA Nears Breakeven.

TORONTO, July 14, 2020 (GLOBE NEWSWIRE) — CB2 Insights Inc. (“CB2” or the “Company”) (CSE: CBII; OTCQB: CBIIF), one of the largest integrative healthcare systems in the United States, today reported its Q1 2020 consolidated financial results for the period ended March 31, 2020. Additional information concerning the Company, including its unaudited condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the period ended March 31, 2020, can be found at www.sedar.com and on the Company’s website (www.cb2insights.com). All amounts are expressed in Canadian dollars unless otherwise noted.CB2 has continued to see growth in patient visits and registrations, while ongoing improvements to its business model and operating structure have led to reduced costs for delivery of services;The...

Continue reading

AAR continues successful Unison Industries partnership with re-selection as exclusive distributor

Wood Dale, Illinois, July 14, 2020 (GLOBE NEWSWIRE) — AAR (NYSE: AIR), a leading provider of aviation services to commercial and government operators worldwide, and Unison Industries jointly announced today the expansion and extension of the longstanding partnership as the exclusive worldwide aftermarket distributor for Unison Industries´ aviation, aerospace, military, civil and land vehicles products. The agreement adds new material content to include new product introduction spanning multiple aircraft platforms.As exclusive distributor, AAR will be responsible for developing customized sales strategies and marketing campaigns, executing growth plans, forecasting, warehousing and performing aftermarket product distribution services of Unison Original Equipment Manufacturer (OEM) replacement parts. In addition, AAR will provide 24/7...

Continue reading

Amalgamated Bank Announces Second Quarter 2020 Earnings Conference Call

NEW YORK, July 14, 2020 (GLOBE NEWSWIRE) — Amalgamated Bank (“Amalgamated”) (Nasdaq: AMAL) today announced that its second quarter 2020 financial results will be released before market open on Tuesday, July 28, 2020.  The Company will host a conference call at 10:00 a.m. Eastern Time on the same day to discuss the financial results.Investors and analysts interested in participating in the call are invited to dial 1-877-407-9716 (international callers please dial 1-201-493-6779) approximately 10 minutes prior to the start of the call.  A live audio webcast of the conference call will be available on the website at https://ir.amalgamatedbank.com/.A replay of the conference call will be available within two hours of the conclusion of the call and can be accessed both online and by dialing 1-844-512-2921 (international callers please...

Continue reading

Gladstone Commercial Corporation Announces Monthly Cash Distributions for July, August and September 2020 and Second Quarter Ended June 30, 2020 Earnings Release and Conference Call Dates

MCLEAN, Va., July 14, 2020 (GLOBE NEWSWIRE) — Gladstone Commercial Corporation (Nasdaq: GOOD) (the “Company”) announced today that its board of directors declared cash distributions for the months of July, August and September 2020 and also announced its plan to report earnings for the second quarter ended June 30, 2020.Cash Distributions:Common Stock: $0.12515 cash distribution per common share for each of July, August and September 2020, payable per Table 1 below.  The Company has paid 186 consecutive monthly cash distributions on its common stock.  Prior to paying distributions on a monthly basis, the Company paid five consecutive quarterly cash distributions.  The Company has never skipped, reduced or deferred a monthly or quarterly common stock distribution since its inception in 2003.Table 1: Summary of common stock cash distributions:Senior...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.